Log In
Print this Print this

BAY 85-8501

  Manage Alerts
Collapse Summary General Information
Company Bayer AG
DescriptionNeutrophil elastase inhibitor
Molecular Target Neutrophil elastase (ELANE) (NE) (HLE)
Mechanism of ActionNeutrophil elastase inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationChronic obstructive pulmonary disease (COPD)
Indication DetailsTreat bronchiectasis
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today